Shareholding14 May 2026, 08:41 am
Riddhish Tanna Increases Stake in Aptus Pharma to 8.64%
AI Summary
Riddhish Natwarlal Tanna acquired 18,000 equity shares of Aptus Pharma Limited on May 11, 2026, increasing his stake from 8.38% to 8.64%. The acquisition was an off-market inter-se transfer among the Promoter Group. The company's equity share capital remains at 68,60,000 shares of ₹10 each after the acquisition.
Key Highlights
- Riddhish Natwarlal Tanna acquired 18,000 shares of Aptus Pharma.
- Tanna's stake in Aptus Pharma increased to 8.64%.
- The acquisition was an off-market transfer within the Promoter Group.
- The acquisition date was May 11, 2026.
- Aptus Pharma's equity share capital remains unchanged.
Price Impact
More from APPL